Fig. 6. In vivo tumor growth inhibition (A) and body weight changes (B) of mice bearing OVCAR8 ovarian cancer xenografts after intravenous treatment with PBS, cMLVs (CPT) (1.8 mg kg^–1), cMLVs (PTX) (4.0 mg kg^–1) and cMLVs (CPT + PTX) (1.8 mg kg^–1 + 4.0 mg kg^–1) on days 0, 3, 6 and 9. Error bars represent standard error of the mean, n = 4 for each treatment group (**p < 0.01; ***p < 0.001).